Ornipressin

Product Overview

Ornipressin, identified by CAS number 3397-23-7, represents a sophisticated synthetic analogue of vasopressin designed for specialized pharmaceutical and research applications. As a modified peptide structure incorporating L-Ornithine, this compound exhibits enhanced stability and specific biological activity profiles compared to native hormones. Our facility produces this material under strict quality control protocols to ensure consistency for downstream formulation and development processes.

This chemical entity is primarily recognized for its role as a vasoconstrictor and hemostatic agent. In the context of industrial pharmaceutical manufacturing, Ornipressin serves as a critical active ingredient or intermediate for developing therapies targeting renal function and vascular regulation. We cater to licensed laboratories and manufacturing entities requiring reliable supply chains for high-value peptide compounds.

Technical Specifications

Quality assurance is paramount in the handling of complex peptide structures. Each batch undergoes rigorous analytical testing including HPLC, mass spectrometry, and physical property verification. The following table outlines the standard specifications for our commercial grade Ornipressin:

Industrial Applications

The primary utility of Ornipressin lies in its pharmacological properties as a vasoconstrictor and renal agent. In professional settings, it is utilized for the synthesis of hemostatic formulations and investigational medicines. Researchers value this compound for its predictable performance benchmark in physiological studies involving vascular tone and fluid balance. Due to its peptide nature, it requires careful handling to maintain structural integrity during the formulation guide phases.

For clients seeking a drop-in replacement for existing supply chains, our material offers an equivalent performance profile with enhanced documentation support. We support various stages of drug development, from early-stage research to commercial scale manufacturing, ensuring that the chemical properties remain stable throughout the production lifecycle.

Storage and Handling

Proper storage is essential to preserve the potency of peptide-based chemicals. Ornipressin should be stored in a cool, ventilated place away from direct sunlight and moisture sources. Containers must remain tightly sealed when not in use to prevent hydrolysis or degradation. We recommend maintaining inventory in temperature-controlled environments to extend shelf life.

Safety protocols dictate the use of appropriate personal protective equipment during handling. While this is a specialized chemical, standard industrial hygiene practices apply to prevent inhalation of powder or skin contact. Our packaging options include 25 kg drums, with flexibility for custom packaging according to customer requirements and logistical needs.

Quality Commitment

As a global manufacturer, we prioritize transparency and compliance. Every shipment is accompanied by a Certificate of Analysis (COA) and relevant safety data sheets. Our commitment to GMP standards ensures that the bulk price reflects not just the material cost, but the value of verified quality and regulatory adherence. Contact our technical team for detailed specifications or to request samples for evaluation.